Quick Answer
Gossamer Bio, Inc. reported Stockholders Equity of -$122.76 million for fiscal year 2025.
Gossamer Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$122.76M | -516.2% |
| 2024 | $29.49M | -53.0% |
| 2023 | $62.77M | +419.7% |
| 2022 | $12.08M | -90.1% |
| 2021 | $121.46M | -62.1% |
| 2020 | $320.68M | -9.0% |
| 2019 | $352.49M | +393.6% |
| 2018 | -$120.07M | -1649.8% |
| 2017 | -$6.86M | -5478.9% |
| 2016 | -$123.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$82.33M | -252.1% | -78.6% |
| June 30, 2025 | -$46.11M | -156.6% | -637.7% |
| March 31, 2025 | -$6.25M | -123.4% | -121.2% |
| December 31, 2024 | $29.49M | -53.0% | -45.5% |
| September 30, 2024 | $54.14M | -48.3% | -33.6% |
| June 30, 2024 | $81.53M | +229.8% | +205.1% |
| March 31, 2024 | $26.72M | +193.9% | -57.4% |
| December 31, 2023 | $62.77M | +419.7% | -40.0% |
- Gossamer Bio, Inc. showed a decrease of -516.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Gossamer Bio, Inc.’s stockholders equity has declined by 99704.9% (from -$123.0 thousand to -$122.76 million).
- The most recent figure is from Gossamer Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: